Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3

Cyclin-Dependent Kinase Inhibitors:  Useful Targets in Cell Cycle Regulation

Thais M. Sielecki, John F. Boylan, Pamela A. Benfield et al. · Journal of Medicinal Chemistry · 2000 · 323 citations

Drug Target, Altmetric Attention Score, Cell Cycle +20

Inhibition of CDKs as a Therapeutic Modality

Edward A. Sausville, J I Johnson, Michael C. Alley et al. · Annals of the New York Academy of Sciences · 2000 · 81 citations

Chemoprevention Strategy, Medicine, Receptor Tyrosine Kinase +15

Indenopyrazoles as Novel Cyclin Dependent Kinase (CDK) Inhibitors

David A. Nugiel, Ana-Marie Etzkorn, Anup Vidwans et al. · Journal of Medicinal Chemistry · 2001 · 77 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Molecular Sciences +15

Synthesis and Evaluation of Indenopyrazoles as Cyclin-Dependent Kinase Inhibitors. 2. Probing the Indeno Ring Substituent Pattern

David A. Nugiel, Anup Vidwans, Anna-Marie Etzkorn et al. · Journal of Medicinal Chemistry · 2002 · 74 citations · Full text

Indenopyrazole-based Cyclin-dependent Kinase, Chemoprevention Strategy, Kinase Atp Pocket +18

Synthesis and Evaluation of Indenopyrazoles as Cyclin-Dependent Kinase Inhibitors. 3. Structure Activity Relationships at C3

Eddy W. Yue, C. Anne Higley, Susan V. DiMeo et al. · Journal of Medicinal Chemistry · 2002 · 47 citations · Full text

Potent Analogues, Molecular Pharmacology, Medicinal Chemistry +15